CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 824	$ (137,859)	$ 85,634
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	174,896	224,109	219,608
Property and equipment impairment expense	0	188,601	0
Goodwill impairment expense	0	23,624	0
Deferred income tax expense (benefit)	3,663	(33,336)	27,840
Amortization of deferred financing origination and debt issuance costs	504	438	359
Stock‑based compensation	16,946	17,288	14,450
Provision for credit losses	0	0	34
Loss (gain) on disposal of assets and businesses, net	12,179	(4,925)	34,293
Unrealized (gain) loss on short-term investment	(2,355)	(105)	2,538
Business acquisition contingent consideration adjustments	(4,900)	(2,600)	0
Changes in operating assets and liabilities:
Accounts receivable	(4,759)	51,498	(12,408)
Other current assets	913	(2,301)	(831)
Inventories	2,840	1,543	(6,017)
Prepaid expenses	(2,177)	1,327	(6,143)
Accounts payable	9,573	(64,501)	(11,429)
Accrued and other current liabilities	23,460	(10,506)	26,814
Net cash provided by operating activities	231,607	252,295	374,742
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(186,316)	(140,297)	(370,869)
Business acquisitions, net of cash acquired	0	(21,038)	(22,215)
Proceeds from sale of assets	23,505	6,236	8,957
Proceeds from note receivable from sale of business	13,000	0	0
Net cash used in investing activities	(149,811)	(155,099)	(384,127)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from borrowings	0	0	30,000
Repayments of borrowings	0	0	(15,000)
Payments of finance lease obligations	(18,513)	(17,676)	(4,663)
Repayments of equipment financing term loans	(3,571)	0	0
Repayments of insurance financing	(4,510)	(970)	0
Payment of financing origination and debt issuance costs	(2,807)	0	(1,179)
Payment of business acquisition deferred cash consideration	(6,773)	0	0
Tax withholdings paid for net settlement of equity awards	(4,200)	(1,909)	(3,543)
Share repurchases	0	(59,108)	(51,738)
Payment of excise taxes on share repurchases	(531)	(444)	0
Net cash used in financing activities	(40,905)	(80,107)	(46,123)
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	40,891	17,089	(55,508)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of year	50,443	33,354	88,862
CASH AND CASH EQUIVALENTS — End of year	$ 91,334	$ 50,443	$ 33,354